Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05315037 · ClinicalTrials.gov registry record · NA

Resistance Training in Type 1 Diabetes Mellitus

A NA study of Type 1 Diabetes, sponsored by University of Louisville.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT05315037 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 15 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05315037, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to learn how different resistance training programs affects blood sugar in young athletes with T1DM.

Conditions Studied

Interventions

  • OTHER Resistance Training

Study Locations (2)

Kentucky

  • Norton Healthcare - Louisville
  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-08-01
Est. Completion 2025-12-30
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT05315037

The ClinicalTrials.gov registry entry for NCT05315037 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Resistance Training is the first listed.

NCT05315037 reports 2 study locations spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05315037 about?

NCT05315037 is a clinical study titled "Resistance Training in Type 1 Diabetes Mellitus". The purpose of this study is to learn how different resistance training programs affects blood sugar in young athletes with T1DM.

What is the current status of trial NCT05315037?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-08-01. Estimated completion is 2025-12-30.

What conditions does trial NCT05315037 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT05315037?

The interventions under investigation include: Resistance Training (OTHER).

Who is sponsoring clinical trial NCT05315037?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05315037 being conducted?

This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.